Levi M - Search Results

1

Cognitive, functional, and quality-of-life outcomes of patients aged 80 and older who survived at least 1 year after planned or unplanned surgery or medical intensive care treatment.

de Rooij SE, Govers AC, Korevaar JC, Giesbers AW, Levi M, de Jonge E. de Rooij SE, et al. Among authors: levi m. J Am Geriatr Soc. 2008 May;56(5):816-22. doi: 10.1111/j.1532-5415.2008.01671.x. Epub 2008 Apr 1. J Am Geriatr Soc. 2008. PMID: 18384589

2

Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects.

de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. de Jonge E, et al. Among authors: levi m. Thromb Haemost. 1998 Feb;79(2):286-90. Thromb Haemost. 1998. PMID: 9493577 Clinical Trial.

3

Current drug treatment strategies for disseminated intravascular coagulation.

de Jonge E, Levi M, Stoutenbeek CP, van Deventer SJ. de Jonge E, et al. Among authors: levi m. Drugs. 1998 Jun;55(6):767-77. doi: 10.2165/00003495-199855060-00004. Drugs. 1998. PMID: 9617592 Review.

4

Disseminated intravascular coagulation.

Levi M, de Jonge E, van der Poll T, ten Cate H. Levi M, et al. Thromb Haemost. 1999 Aug;82(2):695-705. Thromb Haemost. 1999. PMID: 10605770 Review. No abstract available.

5

Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, Büller HR. Levi M, et al. Lancet. 1999 Dec 4;354(9194):1940-7. doi: 10.1016/S0140-6736(99)01264-7. Lancet. 1999. PMID: 10622296

6

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van Der Poll T. de Jonge E, et al. Among authors: levi m. Blood. 2000 Feb 15;95(4):1124-9. Blood. 2000. PMID: 10666180 Free article. Clinical Trial.

7

[Disseminated intravascular coagulation].

Levi M, de Jonge E, ten Cate H. Levi M, et al. Ned Tijdschr Geneeskd. 2000 Mar 4;144(10):470-5. Ned Tijdschr Geneeskd. 2000. PMID: 10726156 Review. Dutch.

8

Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?

Folman CC, Linthorst GE, van Mourik J, van Willigen G, de Jonge E, Levi M, de Haas M, von dem Borne AE. Folman CC, et al. Among authors: levi m. Thromb Haemost. 2000 Jun;83(6):923-30. Thromb Haemost. 2000. PMID: 10896250

9

Current management of disseminated intravascular coagulation.

Levi M, de Jonge E. Levi M, et al. Hosp Pract (1995). 2000 Aug 15;35(8):59-66; quiz 92. doi: 10.3810/hp.2000.08.208. Hosp Pract (1995). 2000. PMID: 10955034

10

Novel approaches to the management of disseminated intravascular coagulation.

Levi M, de Jonge E, van der Poll T, ten Cate H. Levi M, et al. Crit Care Med. 2000 Sep;28(9 Suppl):S20-4. doi: 10.1097/00003246-200009001-00005. Crit Care Med. 2000. PMID: 11007192 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,859 results

Search Page

Filters